Current
21.2×
5-Year Average
20.9×
All-Time High
72.9×
All-Time Low
8.1×
P/FCF Ratio daily chart for Merck & Co. (MRK)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/FCF Ratio for Merck & Co. (MRK) from 2001 to 2025
| 2025 | $260.48B | $12.36B | 21.1× | +7.1× | |
| 2024 | $252.78B | $18.10B | 14.0× | -16.5× | |
| 2023 | $278.46B | $9.14B | 30.5× | +11.3× | |
| 2022 | $281.37B | $14.71B | 19.1× | -0.8× | |
| 2021 | $193.67B | $9.71B | 19.9× | -13.9× | |
| 2020 | $197.36B | $5.82B | 33.9× | +11.8× | |
| 2019 | $220.18B | $9.97B | 22.1× | -0.6× | |
| 2018 | $188.89B | $8.31B | 22.7× | -9.0× | |
| 2017 | $144.67B | $4.56B | 31.7× | +14.1× | |
| 2016 | $154.29B | $8.76B | 17.6× | +5.0× | |
| 2015 | $140.09B | $11.14B | 12.6× | -15.1× | |
| 2014 | $153.69B | $5.54B | 27.7× | +13.9× | |
| 2013 | $139.70B | $10.11B | 13.8× | -0.8× | |
| 2012 | $118.16B | $8.07B | 14.6× | +4.4× | |
| 2011 | $109.32B | $10.66B | 10.3× | -1.3× | |
| 2010 | $105.86B | $9.14B | 11.6× | -26.5× | |
| 2009 | $73.48B | $1.93B | 38.0× | +26.4× | |
| 2008 | $61.19B | $5.27B | 11.6× | -8.5× | |
| 2007 | $120.20B | $5.99B | 20.1× | +4.5× | |
| 2006 | $90.21B | $5.79B | 15.6× | +4.9× | |
| 2005 | $66.28B | $6.21B | 10.7× | +1.1× | |
| 2004 | $67.86B | $7.07B | 9.6× | -2.7× | |
| 2003 | $98.00B | $7.95B | 12.3× | -4.6× | |
| 2002 | $121.28B | $7.16B | 16.9× | -3.1× | |
| 2001 | $127.35B | $6.36B | 20.0× | — |
- 202521.1×
- 202414.0×
- 202330.5×
- 202219.1×
- 202119.9×
- 202033.9×
- 201922.1×
- 201822.7×
- 201731.7×
- 201617.6×
- 201512.6×
- 201427.7×
- 201313.8×
- 201214.6×
- 201110.3×
- 201011.6×
- 200938.0×
- 200811.6×
- 200720.1×
- 200615.6×
- 200510.7×
- 20049.6×
- 200312.3×
- 200216.9×
- 200120.0×
About P/FCF Ratio at Merck & Co. (MRK)
Merck & Co. (MRK) P/FCF ratio is 21.2× as of June 5, 2026. The 5-year average is 20.9×. The sector median currently stands at 19.8×. The current ratio is at the 52th percentile of its own 10-year history.
Merck & Co. (MRK) historical P/FCF ratio has ranged from a low of 8.1× (2008) to a high of 72.9× (2009) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Merck & Co. P/FCF Ratio by Year
Merck & Co. P/FCF Ratio 2025: 21.1×
Merck & Co. (MRK) P/FCF ratio in 2025 was 21.1×, expanded from 14.0× the prior year.
Merck & Co. P/FCF Ratio 2024: 14.0×
Merck & Co. (MRK) P/FCF ratio in 2024 was 14.0×, contracted from 30.5× the prior year.
Merck & Co. P/FCF Ratio 2023: 30.5×
Merck & Co. (MRK) P/FCF ratio in 2023 was 30.5×, expanded from 19.1× the prior year.
Merck & Co. P/FCF Ratio 2022: 19.1×
Merck & Co. (MRK) P/FCF ratio in 2022 was 19.1×, contracted from 19.9× the prior year.
Merck & Co. P/FCF Ratio 2021: 19.9×
Merck & Co. (MRK) P/FCF ratio in 2021 was 19.9×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Merck & Co. (MRK), ranked by P/FCF ratio.
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric